268 related articles for article (PubMed ID: 23920275)
21. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
22. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.
Ather F; Hamidi H; Fejzo MS; Letrent S; Finn RS; Kabbinavar F; Head C; Wong SG
PLoS One; 2013; 8(2):e56112. PubMed ID: 23405260
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF
PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.
Veyrat M; Durand S; Classe M; Glavan TM; Oker N; Kapetanakis NI; Jiang X; Gelin A; Herman P; Casiraghi O; Zagzag D; Enot D; Busson P; Vérillaud B
Oncotarget; 2016 Dec; 7(50):82580-82593. PubMed ID: 27791989
[TBL] [Abstract][Full Text] [Related]
25. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.
Kolev Y; Uetake H; Takagi Y; Sugihara K
Ann Surg Oncol; 2008 Aug; 15(8):2336-44. PubMed ID: 18521687
[TBL] [Abstract][Full Text] [Related]
26. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.
Sen M; Joyce S; Panahandeh M; Li C; Thomas SM; Maxwell J; Wang L; Gooding WE; Johnson DE; Grandis JR
Clin Cancer Res; 2012 Sep; 18(18):4986-96. PubMed ID: 22825581
[TBL] [Abstract][Full Text] [Related]
27. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
28. The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.
Luwor RB; Lu Y; Li X; Mendelsohn J; Fan Z
Oncogene; 2005 Jun; 24(27):4433-41. PubMed ID: 15806152
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis.
Jiang Y; Wu GH; He GD; Zhuang QL; Xi QL; Zhang B; Han YS; Fang J
Nutr Cancer; 2015; 67(8):1314-23. PubMed ID: 26576476
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.
Fan J; Hitosugi T; Chung TW; Xie J; Ge Q; Gu TL; Polakiewicz RD; Chen GZ; Boggon TJ; Lonial S; Khuri FR; Kang S; Chen J
Mol Cell Biol; 2011 Dec; 31(24):4938-50. PubMed ID: 21969607
[TBL] [Abstract][Full Text] [Related]
31. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma.
Hatakeyama H; Cheng H; Wirth P; Counsell A; Marcrom SR; Wood CB; Pohlmann PR; Gilbert J; Murphy B; Yarbrough WG; Wheeler DL; Harari PM; Guo Y; Shyr Y; Slebos RJ; Chung CH
PLoS One; 2010 Sep; 5(9):e12702. PubMed ID: 20856931
[TBL] [Abstract][Full Text] [Related]
32. Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism.
Sellam LS; Zappasodi R; Chettibi F; Djennaoui D; Yahi-Ait Mesbah N; Amir-Tidadini ZC; Touil-Boukoffa C; Ouahioune W; Merghoub T; Bourouba M
Arch Biochem Biophys; 2020 Sep; 690():108479. PubMed ID: 32679194
[TBL] [Abstract][Full Text] [Related]
33. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α.
Chen Y; Zhang J; Zhang M; Song Y; Zhang Y; Fan S; Ren S; Fu L; Zhang N; Hui H; Shen X
Clin Transl Med; 2021 Nov; 11(11):e577. PubMed ID: 34841716
[TBL] [Abstract][Full Text] [Related]
34. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
Kumar S; Donti TR; Agnihotri N; Mehta K
Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
[TBL] [Abstract][Full Text] [Related]
35. UBE2C triggers HIF-1α-glycolytic flux in head and neck squamous cell carcinoma.
Yang YF; Chang YC; Tsai KW; Hung MH; Kang BH
J Cell Mol Med; 2022 Jul; 26(13):3716-3725. PubMed ID: 35615976
[TBL] [Abstract][Full Text] [Related]
36. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
37. Enhanced Aerobic Glycolysis by S-Nitrosoglutathione via HIF-1α Associated GLUT1/Aldolase A Axis in Human Endothelial Cells.
Yan J; Huang X; Zhu D; Lou Y
J Cell Biochem; 2017 Aug; 118(8):2443-2453. PubMed ID: 28121054
[TBL] [Abstract][Full Text] [Related]
38. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
Meng S; Wang G; Lu Y; Fan Z
Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
[TBL] [Abstract][Full Text] [Related]
39. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
[TBL] [Abstract][Full Text] [Related]
40. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
Lu H; Li X; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
